Gastrointestinal Cancer News

Polypectomy entails a “higher risk” with factors such as polyp, patient and physician characteristics as well as polyp indication influencing procedure outcomes, according to a speaker.

In the era of direct-acting antivirals, rates of hepatocellular carcinoma are rising in patients without cirrhosis, particularly Black patients, according to a presentation at The Liver Meeting Digital Experience.

The protective effect of a single flexible sigmoidoscopy screening in older adults was maintained for up 15 years against colorectal cancer incidence and for up to 19 years against mortality, according to a randomized controlled trial.

In this video exclusive with Healio Gastroenterology, Swati G. Patel MD, MS, discussed the U.S. Multi-Society Task Force on Colorectal Cancer’s updated screening recommendations for colorectal cancer.

City of Hope announced Wednesday that it has entered a definitive agreement to acquire Cancer Treatment Centers of America.

Substantial reductions in procedures used to diagnose cancer and in new cancer diagnoses occurred across the U.S. because of the COVID-19 pandemic, according to a review of a large database of U.S. veterans published in Cancer.

Christian S. Hinrichs, MD, is reluctant to give cancer credit for anything good.

The FDA cleared an investigational new drug application for CYNK-101, a natural killer cell therapy for the treatment of patients with advanced HER2/neu-positive gastric or gastroesophageal junction adenocarcinoma.

Racial and ethnic minority populations remain underrepresented in many precision oncology trials relative to their cancer incidence in the U.S., according to study results published in JAMA Network Open.

The FDA granted fast track designation to arfolitixorin for treatment of patients with metastatic colorectal cancer.